Mankind Pharma Limited has informed the Exchange about Schedule of meet
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has informed the exchanges that its officials will participate in the Eleventh Edition of the Ashwamedh, Elara India Dialogue investor conference scheduled for September 2, 2025, in Mumbai. The meetings will include one-on-one and group sessions with investors. The company clarified that no unpublished price-sensitive information will be shared at the event. The schedule is subject to change due to unforeseen circumstances.
This is a routine investor engagement announcement and is unlikely to have any material impact on the stock price. It signals continued interaction with the institutional investor community, which is normal corporate activity.